Reverse T3: The Complete 2026 Guide to rT3, FT3:rT3 Ratio, and How to Clear It

Reverse T3 (rT3) is one of the most-discussed and most-misunderstood markers in thyroid research. It is a metabolite of T4 - chemically identical to active T3 except for which iodine atom is removed from the outer ring - that occupies the T3 receptor without activating it. Under stress, inflammation, fasting, critical illness, or aggressive T4 dosing, the body produces more rT3 and less active T3, functionally suppressing thyroid signaling at the receptor level.

For researchers, clinicians, and chronic-illness patients, the question is not just "what is rT3" but "what does my FT3:rT3 ratio mean and how do I clear elevated rT3?" This guide covers all of that in depth: the biochemistry, the clinical contexts that drive rT3 production, how to interpret the FT3:rT3 ratio with specific reference ranges, and the protocols most commonly used to bring rT3 back down.

Research framing. This article reviews published thyroid pharmacology, deiodinase biology, and the clinical patterns of reverse T3 dominance. It is not medical advice. T3 reference standards on this site are sold strictly for laboratory study and are not approved for human consumption. See our research-use-only disclaimer.

Quick interactive: calculate your ratio

Before diving in, you can use our FT3:rT3 ratio calculator to convert your lab values and see your ratio against the most commonly cited interpretation thresholds.

What Is Reverse T3?

Reverse T3 (3,3',5'-triiodothyronine) is one of three things that can happen to thyroxine (T4) when it gets deiodinated:

1. Outer-ring deiodination by DIO1 or DIO2 removes the iodine at position 5', producing active T3 (3,5,3'-triiodothyronine) that binds and activates the T3 receptor.
2. Inner-ring deiodination by DIO3 removes the iodine at position 5, producing reverse T3 (3,3',5'-triiodothyronine) that binds the T3 receptor competitively but does not activate it.
3. T4 can also be fully degraded through subsequent rounds of deiodination, eventually clearing as iodide and metabolites.

The proportions of these pathways are controlled by the relative activity of the three deiodinase enzymes - DIO1, DIO2, and DIO3 - which is itself regulated by tissue, time of day, nutritional status, inflammation, cortisol, sex hormones, and several other inputs.

rT3 has a very short serum half-life (~5 hours) compared to T3 (~24 hours) and T4 (~7 days), so an elevated serum rT3 means the body is actively producing it at high rate, not that it has accumulated over time.

Why Reverse T3 Rises: The Clinical Drivers

The shift toward rT3 production is an evolutionarily conserved stress adaptation - the body conserves energy when faced with serious physiological challenge by dampening thyroid signaling. The major drivers of this shift:

Acute physiological stress

• Critical illness (the "low T3 syndrome" or "non-thyroidal illness syndrome")
• Major surgery or trauma
• Severe acute infection
• Hospitalization

Chronic physiological stress

• Chronic inflammation (autoimmune, post-viral, low-grade chronic infection)
• Chronic high cortisol from psychological or physical stress
• Fibromyalgia, chronic fatigue syndrome, long COVID
• Untreated insulin resistance and metabolic syndrome
• Heavy metal toxicity

Nutritional / metabolic

• Caloric restriction and extended fasting
• Low-carbohydrate diets sustained for extended periods
• Selenium deficiency (selenium is a required cofactor for the deiodinase enzymes)
• Iron, zinc, or vitamin A deficiency
• Excess PUFA (polyunsaturated fat) intake interferes with mitochondrial function

Iatrogenic / drug-induced

• Aggressive T4 monotherapy (high T4 input drives rT3 production)
• Beta-blockers (especially propranolol)
• Amiodarone
• High-dose glucocorticoids
• Iodinated contrast dyes

Hormonal

• High estrogen states (oral estrogen replacement, pregnancy, BCP use)
• Low progesterone (often paired with high estrogen)
• Low testosterone

The FT3:rT3 Ratio: The Most Useful Single Marker

Because rT3 and T3 compete for the same receptor, the ratio of free T3 to reverse T3 matters more than either value in isolation. A "normal" free T3 with a high rT3 means the active signal is being drowned out by the inhibitory signal.

Interpretation thresholds (most commonly cited)

These thresholds vary slightly across clinical sources, but the most widely-used research-community interpretations cluster around these values:

Important caveat on units. Lab values come in different units depending on the lab. To use the ratio:

• Free T3 should be in pg/mL (most US labs report pg/mL; if your lab gives pmol/L, divide by 1.536)
• Reverse T3 should be in ng/dL (most US labs report ng/dL; if your lab gives ng/mL, multiply by 100)

Our FT3:rT3 ratio calculator handles all the unit conversions automatically.

Why the ratio matters more than either value alone

Two patients with "normal" free T3 (say 3.2 pg/mL) can have totally different functional thyroid status:

• Patient A: Free T3 3.2 pg/mL, rT3 12 ng/dL → ratio 26.7 → excellent active signal
• Patient B: Free T3 3.2 pg/mL, rT3 35 ng/dL → ratio 9.1 → rT3 dominance, functionally hypothyroid

This is why TSH and free T3 alone routinely miss the patients with the worst functional thyroid status. The ratio is what reveals the true signaling environment at the receptor.

How to Clear Elevated Reverse T3

The general principle for clearing rT3 dominance is to reduce the inputs that drive rT3 production while saturating the T3 receptors with active T3. The two interventions go together: reducing rT3 production without supplying T3 leaves the system hypothyroid; supplying T3 without addressing the root drivers means rT3 will return once T3 dosing stops.

Step 1: Address the underlying driver(s)

The single highest-leverage move is identifying and treating the upstream cause of rT3 elevation. The most common targets in chronic illness:

• Lower aggressive T4 dosing. If on T4 monotherapy at high doses (>150 mcg/day with persistent symptoms), reducing T4 alone can lower rT3.
• Treat chronic inflammation. Source-specific - autoimmune workup, viral reactivation screen, gut barrier work, dental/sinus infection check.
• Restore selenium. 200 mcg/day of selenomethionine for 8-12 weeks is the most cited protocol; selenium is essential for DIO2 activity.
• Reduce psychological + physiological stressors. Cortisol-driven rT3 will not resolve without addressing the cortisol input.
• Adequate calories and carbohydrate. Caloric restriction and very-low-carb diets drive rT3 up; restoring nutrition resolves this driver.
• Address iron deficiency. Ferritin below 70 ng/mL meaningfully impairs T4-to-T3 conversion.
• Reduce PUFA load. Reducing seed oils to <2% of daily calories is the bioenergetic-school approach.

Step 2: The cyclic T3 (Wilson's WT3) protocol

For research-context use, the most commonly cited rT3-clearing protocol is Dr. Denis Wilson's WT3 protocol, which uses sustained-release T3 (SR-T3) to saturate the T3 receptors and overwhelm the deiodinase imbalance:

The premise is that sustained T3 saturation suppresses TSH → reduces T4 → reduces rT3 substrate → and directly downregulates DIO3 activity. After 3 weeks of sustained physiological temperatures, the deiodinase balance has reset and the wean-down allows endogenous conversion to take over.

For details on SR-T3 pharmacokinetics and why it is the formulation of choice for this protocol, see our sustained release T3 complete guide.

Step 3: Combination T4 + SR-T3 (lower-intensity approach)

For research subjects who do not have severe rT3 dominance, a less aggressive combination approach often works:

What NOT to do

A few common mistakes in the rT3 conversation:

• Cytomel-only with single morning dose. Produces a sharp peak then a long trough that doesn't saturate T3 receptors for long enough to suppress DIO3.
• Adding T3 to a high T4 dose without reducing T4. Drives total thyroid signaling supraphysiologically without addressing the rT3 substrate.
• T3-only at very high doses without temperature monitoring. The WT3 protocol depends on temperature as the titration endpoint; without it, dosing is blind.
• Ignoring the underlying driver. rT3 will return after any cyclic T3 protocol if the inflammation, stress, or nutritional issue driving it remains.

Reverse T3 Lab Testing: What to Order and Why

For a complete rT3 workup, the most useful panel includes:

Reverse T3 specifically must be ordered as a separate test - it is not part of a standard thyroid panel. Most major labs (Quest, LabCorp) offer it; some require physician justification beyond a standard hypothyroidism screen.

Calculator and Related Reading

• FT3:rT3 ratio calculator - convert lab values across units, see your ratio against interpretation thresholds
• T3 dosing & conversion calculator - convert between T4, Cytomel, SR-T3, and NDT equivalents
• Sustained Release T3 (SR-T3): The Complete 2026 Guide
• The Wilson's T3 Protocol (WT3): A Step-by-Step Guide

Frequently Asked Questions

What is reverse T3?

Reverse T3 (rT3) is a metabolite of T4 thyroid hormone produced by the type 3 deiodinase enzyme (DIO3). Chemically it is 3,3',5'-triiodothyronine - the same molecule as active T3 (3,5,3'-triiodothyronine) except for which iodine atom is removed from the outer ring. rT3 binds to the T3 receptor competitively but does not activate it, effectively suppressing thyroid signaling. It rises in response to physiological stress, inflammation, fasting, critical illness, and aggressive T4 dosing.

What is a good FT3:rT3 ratio?

The most commonly cited interpretation thresholds for the free T3 (pg/mL) to reverse T3 (ng/dL) ratio: >20 is excellent (active T3 dominates), 15-20 is adequate, 10-15 is borderline rT3 dominance, and <10 indicates rT3 dominance with functional hypothyroidism likely despite otherwise "normal" labs. Use our calculator to handle the unit conversions automatically.

What causes high reverse T3?

The major drivers of elevated rT3 are: physiological stress (critical illness, surgery, trauma, chronic inflammation), nutritional stress (caloric restriction, low-carb diets, selenium deficiency, iron deficiency), drug effects (aggressive T4 monotherapy, beta-blockers, amiodarone, glucocorticoids), and hormonal patterns (high estrogen, low progesterone, low testosterone). The body produces rT3 as a conserved stress adaptation to dampen thyroid signaling under challenging conditions.

How do you clear high reverse T3?

The combined approach is: (1) address the upstream driver - reduce excess T4 dose if on T4-only, treat chronic inflammation, restore selenium and iron, reduce stressors and caloric restriction; and (2) saturate T3 receptors with sustained-release T3 (SR-T3) using the Wilson's WT3 cyclic protocol - 7.5 mcg every 12 hours, titrated up until body temperature sustains at 98.6°F for 3 consecutive weeks, then weaned back down. The SR-T3 saturates the T3 receptor while suppressing TSH and reducing T4 substrate for further rT3 production.

How long does it take to clear reverse T3?

In the Wilson's WT3 protocol, the titration-up phase typically takes 2-6 weeks to reach the temperature target, followed by 3 consecutive weeks of sustained 98.6°F temperatures, then a 2-6 week wean. Total protocol duration is typically 7-15 weeks. Lab evidence of rT3 normalization (drop into single digits ng/dL with rising FT3) is usually seen within 4-8 weeks of starting an effective dose.

Can high reverse T3 cause weight gain?

Yes - functionally. rT3 dominance suppresses thyroid signaling at the receptor regardless of what "free T3" the lab reports, which means reduced metabolic rate, reduced thermogenesis, reduced energy expenditure, and a tendency toward weight gain (especially around the midsection from associated cortisol patterns). Standard TSH/free T3 panels often miss this, which is why patients with rT3 dominance frequently describe themselves as "stuck" on thyroid medication that doesn't seem to be helping.

Is reverse T3 the same as Cytomel or T3 medication?

No. Cytomel (liothyronine) is the medication form of active T3 (3,5,3'-triiodothyronine) - the hormone that activates the T3 receptor. Reverse T3 (3,3',5'-triiodothyronine) is a different molecule produced by the body from T4; it occupies the same receptor without activating it. Dosing Cytomel or SR-T3 is one of the methods used to overwhelm and clear endogenously produced reverse T3.

What lab tests should I order to check for reverse T3 dominance?

A complete rT3 workup includes: TSH, free T4, free T3, reverse T3 (must be ordered separately - not in standard panels), TPO and Tg antibodies, ferritin, selenium, vitamin D 25-OH, and a 4-point salivary cortisol. All major US labs (Quest, LabCorp) offer reverse T3 testing; some practitioners and lab portals require physician sign-off beyond a standard hypothyroidism screen.

Does selenium lower reverse T3?

Yes, indirectly. Selenium is a required cofactor for the type 1 and type 2 deiodinase enzymes (DIO1, DIO2) that produce active T3. Selenium deficiency impairs DIO2 activity specifically, shifting T4 conversion toward the rT3-producing DIO3 pathway. Selenium repletion (commonly 200 mcg/day of selenomethionine for 8-12 weeks) restores DIO1/DIO2 activity and tilts the deiodinase balance back toward T3 production. Selenium is one of the cheapest and most evidence-supported interventions for the rT3-dominant pattern.

Will Cytomel lower reverse T3 better than sustained release T3?

Sustained release T3 (SR-T3) generally produces better rT3-clearing results than Cytomel for one pharmacokinetic reason: SR-T3 maintains receptor saturation for longer per dose, giving the deiodinase system more sustained signal to downregulate DIO3 activity. Cytomel produces a brief spike followed by a trough; the brief peak suppresses TSH but the trough allows DIO3 to recover. The Wilson's WT3 protocol is specifically built around SR-T3 for this reason.

Closing Note

Reverse T3 is one of the most consequential markers in thyroid research because it explains why so many patients with "normal" TSH and free T3 still feel functionally hypothyroid. Understanding the FT3:rT3 ratio, the upstream drivers, and the protocols (especially Wilson's cyclic SR-T3) for clearing rT3 dominance gives researchers and clinicians a sharper lens on chronic-illness thyroid presentations than TSH alone can ever provide.

For the SR-T3 reference standards used in the Wilson's WT3 protocol - HPMC + MCC only, no allergen-class excipients - see our SRT3 catalog. All compounds discussed here are sold strictly for laboratory study and are not approved for human consumption.